FridayJun 27, 2025 10:00 am

Research Links Key Proteins to the Growth of Brain Tumors

University of Plymouth researchers in the UK have identified the proteins that underlie the growth and development of common brain tumors. Their findings could, in the long run, trigger the development of new treatments which are less invasive.  Through investigations undertaken at labs at the Plymouth Science Park, PhD students, together with other scientists studied the molecular subtypes of tumors called meningiomas. They found that ANXA3, a type of protein, was a key driver behind the growth of some meningioma cells. By inhibiting the functioning of these proteins, the team was able to slow down, and in some instances, altogether…

Continue Reading

FridayJun 27, 2025 9:45 am

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100

The new FDA voucher program aims to speed approval of drugs aligned with national health priorities. NRX-100, a preservative-free ketamine, is also under an Abbreviated New Drug Application (“ANDA”) with a priority review request. NRx has submitted full CMC data and draft labeling for NRX-100, meeting key Commissioner’s National Priority Voucher pre-qualification criteria. The company’s U.S.-based manufacturing aims to reduce foreign supply chain dependence and address diversion concerns. A patent on the preservative-free process and a citizen petition to withdraw preserved ketamine could bolster NRx’s market position. NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company developing innovative treatments for suicidal depression and…

Continue Reading

ThursdayJun 26, 2025 10:00 am

Why Public Interest in Mitochondrial Function Testing is Growing

Today, more ordinary people are taking an interest in tracking their mitochondrial health in order to take concrete steps to improve their overall wellness and boost longevity. Previously, such interest was a mainstay among elite athletes, scientists and biohacking enthusiasts. Why are more people choosing to have their mitochondrial health tested?  For starters, mitochondria are powerhouses inside body cells. These organelles play several vital roles, such as generating energy for cellular use, participating in the immune system’s response to pathogens, contributing to cell signaling, and playing a role in programmed cell death (aka apoptosis). Mitochondrial health is therefore essential to…

Continue Reading

ThursdayJun 26, 2025 9:45 am

Lantern Pharma Inc.’s (NASDAQ: LTRN) AI-Powered Platform Delivers Promising and Durable Results in Lung Cancer Trial

Lantern Pharma uses a proprietary AI platform, RADR®, to guide its oncology drug development, enabling rapid drug candidate identification and targeted trial design based on genomic and biomarker data. A Phase 2 trial patient achieved a complete response in their primary cancer lesions after multiple prior therapies failed and has remained responsive to LP-300 for two years signaling durable clinical benefit in this challenging population. The target population, never-smokers with non-small cell lung cancer, represents a growing global unmet need estimated at over $4 billion annually. Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company leveraging artificial intelligence and machine learning…

Continue Reading

TuesdayJun 24, 2025 10:00 am

Could Wheat Germ Hold the Key to Supercharging Immunotherapy? New Research Hopes to Find Out

An ongoing clinical trial at the Comprehensive Cancer Center at UC Davis seeks to find out whether fermented wheat germ could help cancer patients undergoing immunotherapy have better outcomes and live full lives, or even beat cancer.  This pioneering study is being conducted by Joseph Tuscano, an oncologist specializing in blood cancers like multiple myeloma, leukemia and lymphoma. This research is being funded by the family of a patient who succumbed to cancer but had previously shown remarkable improvement after using fermented wheat germ to supplement his immunotherapy. The Veterans Administration is also funding the study.  The use of fermented…

Continue Reading

FridayJun 20, 2025 10:00 am

How Robotics Technology is Transforming Healthcare

Robotics is playing an ever-increasing role in revolutionizing healthcare. The medical industry is playing a leading role in the adoption of robotics and the pace at which these technologies are being adopted is accelerating. It is therefore not surprising that the market for medical robotics is forecast to grow from $16.6bn to $63.8bn between 2023 and 2032. Several applications of these technologies are justifying further deployment.  Speeding up diagnosis  Intuitive, a U.S. firm, developed a robotic-assisted system and platform called Ion. This tool and the supporting system is geared at conducting bronchoscopies in a minimally invasive way in order to…

Continue Reading

FridayJun 20, 2025 9:45 am

Nutriband Inc. (NASDAQ: NTRB) Reimagining Drug Safety Through Scalable Innovation

Nutriband Inc. has been granted a new U.S. patent for its AVERSA(TM) transdermal abuse-deterrent technology, expanding its domestic IP coverage AVERSA(TM) is designed to prevent misuse, abuse, and accidental exposure of transdermal drugs with abuse potential, such as fentanyl With overdose deaths still plaguing the U.S., Nutriband’s platform has the potential to enhance drug safety across multiple therapeutic categories The opioid crisis remains one of the most persistent public health emergencies in the U.S. While state and federal initiatives have helped curb some of the worst-case trajectories, more than 100,000 Americans still die each year from drug overdoses, a significant proportion linked to synthetic…

Continue Reading

WednesdayJun 18, 2025 10:30 am

Soligenix Inc. (NASDAQ: SNGX) Proprietary Therapy Shows Promise in Treatment of Psoriasis

Psoriasis affects approximately 3% of the adult population in the United States, translating to more than 7.5 million individuals. By using visible light, Soligenix’s SGX302 aims to mitigate risks while effectively reducing inflammation and promoting skin healing. A phase 2a study demonstrated that SGX302 was well tolerated, with no significant adverse events reported. Psoriasis is more than just a skin condition — it’s a lifelong autoimmune disorder that disrupts daily life with painful, inflamed patches and an emotional toll that can be just as severe as the physical symptoms. Soligenix (NASDAQ: SNGX) is at the forefront of developing innovative therapies…

Continue Reading

TuesdayJun 17, 2025 10:00 am

Study Finds the Overall Prevalence of Psoriasis in the US Unchanged

A recently published analysis that appeared in the Journal of American Academy of Dermatology has concluded that the general percentage of adults in the U.S. diagnosed with psoriasis remains unchanged at 3% over the past 10 years. However, the investigators mention several points of concern that aren’t reflected in this general summary.  For starters, they point out that the population in America has expanded. Consequently, a stable overall percentage of individuals diagnosed with psoriasis shouldn’t be taken to mean that the caseload has decreased. For example, at the current U.S. population, 3% translates into approximately 8 million individuals, which is…

Continue Reading

TuesdayJun 17, 2025 9:45 am

Soligenix Inc. (NASDAQ: SNGX) Makes Advancement in Proprietary Treatment for Behçet’s Disease

Behçet’s disease is more prevalent in countries along the Silk Road, including Türkiye, Iran and Japan. Even with treatment, symptoms can continue occurring for many patients and significantly affect their quality of life and productivity. Soligenix has initiated a clinical trial to evaluate the safety, tolerability and preliminary efficacy of SGX945 in patients suffering from oral ulcers. Behçet’s disease is a rare, chronic autoimmune disorder characterized by inflammation of blood vessels, leading to a range of symptoms including painful mouth and genital ulcers, eye inflammation and skin lesions. With limited treatment options available, Soligenix (NASDAQ: SNGX) is at the forefront of…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000